Fortrea Holdings Inc (FTRE) Stock Price, Quote & News

Company Profile

Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical pharmacology, such as clinical research units, external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics, modeling and simulation, and biometrics; and clinical development, including phase I through IV clinical and...

Industry: Biotechnology

Sector: Healthcare

Phone: 877 495 0816

Website: www.fortrea.com

Address:

8 Moore Drive, Durham, United States

deedeethegenius Jul. 29 at 6:13 PM

$PBI $SONO $FTRE

0 · Reply

EarningsInsider Jul. 29 at 1:17 PM

https://www.marketbeat.com/earnings/reports/2026-7-29-fortrea-holdings-inc-stock/ $FTRE Fortrea Earnings Transcript

0 · Reply

StocktwitsEarnings Jul. 29 at 10:42 AM

$FTRE Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.14 up 96.62% YoY • Reported revenue of $678.2M down -4.52% YoY • Fortrea increased its full-year 2026 guidance, now targeting revenues in the range of $2,620 million to $2,690 million and adjusted EBITDA in the range of $205 million to $220 million.

0 · Reply

STRelativeStrength Jul. 23 at 3:05 PM

$FTRE undiscovered breakout with 201 watchers

0 · Reply

StockConsultant Jul. 23 at 4:07 AM

$FTRE Fortrea stock, nice close and narrow range breakout from Stocks to Watch at https://stockconsultant.com/?FTRE Breakout trade CONFIRMED breakout above 18.45 Target: 21.14, 14.4% Stop: 17.55 Loss: 5.1% P/L ratio: 2.8 : 1 - Good BULLISH [Timing] Strong bullish 3 day candlestick pattern. [Timing] CONFIRMED breakout above 18.45, no resistance in area just above. BEARISH [Positioning] Intermediate trend bearish, Unsustainable uptrend, may turn sideways.

1 · Reply

StockConsultant Jul. 1 at 3:01 PM

$FTRE Fortrea stock with a top of range bull flag breakout at https://stockconsultant.com/?FTRE Breakout trade CONFIRMED breakout above 18.3 Target: 21.19, 15.8% Stop: 17.36 Loss: 5.2% P/L ratio: 3 : 1 - Good BULLISH [Timing] Strong bullish 3 day candlestick pattern. [Timing] CONFIRMED breakout above 18.3, no resistance in area just above. BEARISH [Positioning] 1 Day Price change strong up, may pause [Positioning] Short term typical rally, rally may start to slow. [Positioning] Overbought, odds favor short trades. [Positioning] Intermediate trend bearish, Unsustainable uptrend, may turn sideways.

0 · Reply

Paulisdead Jun. 26 at 1:45 PM

$FTRE this thing was dragged down by LabCorps and then spun off with a ton of debt. Their balance sheet is significantly improved and once the CRO market rebounds in a few years, this thing will double. With a current valuation below annual revenue, it’s a buy and hold for the long term based on projected earnings growth opportunities

0 · Reply

anachartanalyst Jun. 24 at 11:01 AM

$FTRE https://anachart.com/wp-content/uploads/2026/06/1782298867_soc-img.jpg

0 · Reply

Zjohnson724 Jun. 22 at 3:26 PM

$CRM my life experience the hedge funds and market players will drop something to extreme extreme lows if they believe it’s a profitable opportunity I’ve seen it with $JXN $FTRE

1 · Reply

Mateojam123 Jun. 18 at 12:46 AM

$FTRE haven't followed this. Anybody know why the earnings expectations are lower than 2025 ?

1 · Reply

Fortrea price target raised to $22 from $20 at Citi

2026-07-30T12:39:36.000Z - 4 days ago

Fortrea price target raised to $20 from $18 at Deutsche Bank

2026-07-30T11:55:39.000Z - 4 days ago

Fortrea price target raised to $23 from $21 at Baird

2026-07-30T09:10:16.000Z - 5 days ago

Fortrea price target raised to $22 from $18 at Barclays

2026-07-29T17:05:23.000Z - 5 days ago

Fortrea price target raised to $25 from $20 at Evercore ISI

Jul 29, 2026, 8:00 AM EDT - 5 days ago

Fortrea Holdings Earnings Call Transcript: Q2 2026

Jul 29, 2026, 8:00 AM EDT - 5 days ago

Fortrea Holdings Slides: Q2 2026

Jul 29, 2026, 8:00 AM EDT - 5 days ago

Fortrea Holdings Earnings release: Q2 2026

Jul 29, 2026, 8:00 AM EDT - 5 days ago

Fortrea Holdings Quarterly report: Q2 2026

2026-07-29T10:43:14.000Z - 5 days ago

Fortrea reports Q2 adjusted EPS 23c, consensus 18c

Jul 29, 2026, 6:30 AM EDT - 5 days ago

Fortrea Reports Second Quarter 2026 Results

Jul 13, 2026, 9:00 AM EDT - 21 days ago

Fortrea Announces Date for Second Quarter 2026 Financial Results and Conference Call

2026-07-13T11:45:26.000Z - 21 days ago

Fortrea price target raised to $16 from $13 at Mizuho

2026-06-26T11:10:11.000Z - 5 weeks ago

Fortrea CFO Jill McConnell to step down, Jason Knoblauch to succeed

Jun 26, 2026, 7:00 AM EDT - 5 weeks ago

Fortrea Names Jason Knoblauch as Chief Financial Officer

2026-06-24T08:55:51.000Z - 5 weeks ago

Fortrea price target raised to $18 from $16 at Barclays

Jun 10, 2026, 4:15 PM EDT - 7 weeks ago

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Jun 9, 2026, 8:00 AM EDT - 7 weeks ago

Fortrea Holdings Transcript: AGM 2026

Jun 4, 2026, 8:45 AM EDT - 2 months ago

Fortrea Holdings Transcript: Jefferies Global Healthcare Conference 2026

Jun 2, 2026, 6:00 PM EDT - 2 months ago

Fortrea to Attend Jefferies Global Healthcare Conference

2026-05-12T12:44:38.000Z - 2 months ago

Fortrea price target raised to $13 from $11 at Mizuho

2026-05-07T20:33:28.000Z - 3 months ago

Fortrea price target raised to $14 from $11 at Deutsche Bank

2026-05-07T10:25:14.000Z - 3 months ago

Fortrea price target raised to $16 from $11 at Barclays

2026-05-07T09:20:20.000Z - 3 months ago

Fortrea price target raised to $20 from $15 at Baird

2026-05-07T09:19:56.000Z - 3 months ago

Fortrea price target raised to $20 from $15 at Baird

2026-05-07T08:48:22.000Z - 3 months ago

Fortrea price target raised to $20 from $16 at Citi

2026-05-07T05:22:58.000Z - 3 months ago

Fortrea price target raised to $18 from $15 at TD Cowen

2026-05-07T04:22:31.000Z - 3 months ago

Fortrea price target raised to $19 from $16 at Truist

May 5, 2026, 8:00 AM EDT - 3 months ago

Fortrea Holdings Earnings Call Transcript: Q1 2026

May 5, 2026, 8:00 AM EDT - 3 months ago

Fortrea Holdings Slides: Q1 2026

May 5, 2026, 8:00 AM EDT - 3 months ago

Fortrea Holdings Earnings release: Q1 2026

May 5, 2026, 8:00 AM EDT - 3 months ago

Fortrea Holdings Quarterly report: Q1 2026

May 5, 2026, 6:00 AM EDT - 3 months ago

Fortrea Reports First Quarter 2026 Results

Apr 27, 2026, 8:00 AM EDT - 3 months ago

Fortrea Holdings Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 3 months ago

Fortrea Holdings Proxy statement: Proxy filing

Apr 21, 2026, 8:45 AM EDT - 3 months ago

Fortrea Announces Date for First Quarter 2026 Financial Results and Conference Call

Apr 7, 2026, 7:00 AM EDT - 4 months ago

Fortrea Unveils Fortrea Intelligent Technology™ to Help Sponsors and Sites Run Smarter, More Integrated Trials

Feb 26, 2026, 8:00 AM EST - 5 months ago

Fortrea Holdings Earnings Call Transcript: Q4 2025

Feb 26, 2026, 8:00 AM EST - 5 months ago

Fortrea Holdings Annual report: Q4 2025

Feb 26, 2026, 8:00 AM EST - 5 months ago

Fortrea Holdings Earnings release: Q4 2025

Feb 26, 2026, 8:00 AM EST - 5 months ago

Fortrea Holdings Slides: Q4 2025

Feb 26, 2026, 6:00 AM EST - 5 months ago

Fortrea Reports Fourth Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance

Feb 17, 2026, 7:00 AM EST - 5 months ago

Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services

Jan 29, 2026, 8:08 AM EST - 6 months ago

Fortrea Announces Date for Fourth Quarter and Full Year 2025 Financial Results and Conference Call

Jan 20, 2026, 3:38 PM EST - 6 months ago

Fortrea Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fortrea Holdings, Inc. - FTRE

Jan 13, 2026, 2:15 PM EST - 7 months ago

Fortrea Holdings Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 2:15 PM EST - 7 months ago

Fortrea Holdings Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 9, 2026, 11:24 AM EST - 7 months ago

Fortrea Announces Updated Presentation Time at Upcoming J.P. Morgan Healthcare Conference

Jan 6, 2026, 7:00 AM EST - 7 months ago

Fortrea to Present at Upcoming J.P. Morgan Healthcare Conference

Dec 4, 2025, 7:00 AM EST - 8 months ago

SCTbio and Fortrea Forge Strategic Collaboration to Accelerate Cell and Gene Therapy Development and Delivery

Dec 3, 2025, 10:50 AM EST - 8 months ago

Fortrea Holdings Transcript: Evercore ISI 8th Annual HealthCONx Conference

Dec 2, 2025, 1:00 PM EST - 8 months ago

Fortrea Holdings Transcript: Citi Annual Global Healthcare Conference 2025

Dec 2, 2025, 11:00 AM EST - 8 months ago

Fortrea Holdings Slides: Investor presentation

Nov 25, 2025, 7:00 AM EST - 8 months ago

Fortrea to Present at Upcoming Citi and Evercore Healthcare Conferences

Nov 24, 2025, 7:00 AM EST - 9 months ago

Fortrea Completes $75.7 Million Senior Notes Tender Offer Utilizing Cash on Hand

Nov 17, 2025, 7:00 AM EST - 9 months ago

Fortrea Appoints Agnieszka Gallagher as General Counsel

Nov 12, 2025, 7:06 AM EST - 9 months ago

Velocity Clinical Research Appoints Former Fortrea Executive, Andrew Reina, as Chief Revenue Officer

Nov 5, 2025, 8:00 AM EST - 9 months ago

Fortrea Holdings Earnings Call Transcript: Q3 2025

Nov 5, 2025, 8:00 AM EST - 9 months ago

Fortrea Holdings Quarterly report: Q3 2025

Nov 5, 2025, 8:00 AM EST - 9 months ago

Fortrea Holdings Earnings release: Q3 2025

Nov 5, 2025, 8:00 AM EST - 9 months ago

Fortrea Holdings Slides: Q3 2025

Nov 5, 2025, 6:30 AM EST - 9 months ago

Fortrea Reports Third Quarter 2025 Results

Oct 15, 2025, 7:00 AM EDT - 10 months ago

Fortrea Announces Date for Third Quarter 2025 Financial Results and Conference Call

Sep 22, 2025, 4:30 PM EDT - 11 months ago

Fortrea Appoints William Sharbaugh to Board of Directors

Aug 25, 2025, 9:55 AM EDT - 1 year ago

Investors who lost money with Fortrea Holdings Inc. (NASDAQ: FTRE) should contact the Shareholders Foundation in connection with Lawsuit

Aug 6, 2025, 8:00 AM EDT - 1 year ago

Fortrea Holdings Earnings Call Transcript: Q2 2025

Aug 6, 2025, 8:00 AM EDT - 1 year ago

Fortrea Holdings Quarterly report: Q2 2025

Aug 6, 2025, 8:00 AM EDT - 1 year ago

Fortrea Holdings Earnings release: Q2 2025

Aug 6, 2025, 8:00 AM EDT - 1 year ago

Fortrea Holdings Slides: Q2 2025

Aug 6, 2025, 6:30 AM EDT - 1 year ago

Fortrea Reports Second Quarter 2025 Results

Aug 5, 2025, 6:00 PM EDT - 1 year ago

Fortrea Appoints Tracy Krumme as Senior Vice President, Investor Relations

Jul 31, 2025, 10:39 AM EDT - 1 year ago

FTRE Shareholders Have the Right to Lead the Fortrea Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group Before the Final Deadline - FTRE

Jul 22, 2025, 8:36 AM EDT - 1 year ago

FTRE DEADLINE: Lose Money on Fortrea Holdings Inc. (NASDAQ:FTRE)? You may have been Affected by Fraud and are Urged to Contact BFA Law by August 1

Jul 16, 2025, 7:00 AM EDT - 1 year ago

Fortrea Announces Date for Second Quarter 2025 Financial Results and Conference Call

Jul 10, 2025, 8:18 AM EDT - 1 year ago

FTRE COURT NOTICE: Fortrea Holdings Inc. Investors may have been Affected by Fraud – Contact BFA Law by the August 1 Legal Deadline (NASDAQ:FTRE)

Jun 28, 2025, 7:46 AM EDT - 1 year ago

FTRE INVESTOR DEADLINE: Fortrea Holdings Inc. Investors with Losses may have been Affected by Fraud – Contact BFA Law by August 1 Court Deadline (NASDAQ:FTRE)

Jun 24, 2025, 7:00 AM EDT - 1 year ago

Fortrea & Emery Pharma Announce Strategic Collaboration to Deliver FDA Compliant Drug-Drug-Interaction Studies Using Rifampin

Jun 20, 2025, 9:07 AM EDT - 1 year ago

FTRE COURT REMINDER: Fortrea Holdings Inc. Investors that Lost Money may have been Affected by Fraud -- Contact BFA Law by August 1 Court Deadline (NASDAQ:FTRE)

deedeethegenius Jul. 29 at 6:13 PM

$PBI $SONO $FTRE

0 · Reply

EarningsInsider Jul. 29 at 1:17 PM

https://www.marketbeat.com/earnings/reports/2026-7-29-fortrea-holdings-inc-stock/ $FTRE Fortrea Earnings Transcript

0 · Reply

StocktwitsEarnings Jul. 29 at 10:42 AM

0 · Reply

STRelativeStrength Jul. 23 at 3:05 PM

$FTRE undiscovered breakout with 201 watchers

0 · Reply

StockConsultant Jul. 23 at 4:07 AM

1 · Reply

StockConsultant Jul. 1 at 3:01 PM

0 · Reply

Paulisdead Jun. 26 at 1:45 PM

0 · Reply

anachartanalyst Jun. 24 at 11:01 AM

$FTRE https://anachart.com/wp-content/uploads/2026/06/1782298867_soc-img.jpg

0 · Reply

Zjohnson724 Jun. 22 at 3:26 PM

$CRM my life experience the hedge funds and market players will drop something to extreme extreme lows if they believe it’s a profitable opportunity I’ve seen it with $JXN $FTRE

1 · Reply

Mateojam123 Jun. 18 at 12:46 AM

$FTRE haven't followed this. Anybody know why the earnings expectations are lower than 2025 ?

1 · Reply

Trader_Ty Jun. 17 at 4:06 PM

$FTRE out here with the L

0 · Reply

Trader_Ty Jun. 15 at 7:47 PM

$FTRE added for trade

0 · Reply

Trader_Ty Jun. 12 at 7:18 PM

$FTRE (weekly/daily) Nice looking flaggy pennant thingy on the daily

1 · Reply

SuperGreenToday Jun. 3 at 12:50 AM

$FTRE Share Price: $15.38 Contract Selected: Nov 20, 2026 $15 Calls Buy Zone: $2.21 – $2.73 Target Zone: $3.79 – $4.64 Potential Upside: 62% ROI Time to Expiration: 170 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Trader_Ty Jun. 1 at 11:57 AM

$FTRE Would want dip toward to EMAs or the breakout before adding

0 · Reply

StockConsultant May. 29 at 2:55 AM

$FTRE Fortrea stock, great setup and rally off support at https://stockconsultant.com/?FTRE

0 · Reply

belugatrade May. 28 at 1:47 PM

$FTRE higher base is now 13

0 · Reply

LewisDaKat May. 5 at 7:00 PM

$FTRE Fortrea (FTRE) Q1 2026 Earnings Transcript https://marketwirenews.com/stock/ftre/news/fortrea-ftre-q1-2026-earnings-transcript-4703803164741851.html?utm_source=stocktwits

0 · Reply

STACKD0E May. 5 at 1:29 PM

$DOCN $FTRE $TLIH

0 · Reply

StocktwitsEarnings May. 5 at 10:17 AM

$FTRE Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.25 up 96.00% YoY • Reported revenue of $636.5M down -2.27% YoY • Fortrea reiterated its full year 2026 guidance, targeting revenues between $2.55B and $2.65B, and adjusted EBITDA in the range of $190 million to $220 million.

0 · Reply

anachartanalyst Apr. 8 at 4:02 PM

$FTRE https://anachart.com/wp-content/uploads/ana_temp/1775664102_soc-img.jpg

0 · Reply

Market Cap	1.82B
Revenue (ttm)	2.72B
Net Income (ttm)	-986.20M
EPS (ttm)	N/A
PE Ratio	31.80
Forward PE	22.10
Profit Margin	-36.21%
Debt to Equity Ratio	2.00

Volume	3,140,100
Avg Vol	1,495,868
Day's Range	N/A - N/A
Shares Out	95.10M
Stochastic %K	39%
Beta	2.03
Analysts	Sell
Price Target	$20.65